
Annual Report and Accounts 2022
3
Strategic Report
Maximising value for all stakeholders
The past year has seen unprecedented
upheaval and change at Capricorn. A
proposed recommended takeover by
Tullow Oil plc was announced in June 2022
with the recommendation subsequently
withdrawn by the Board in response to
shareholders’ objections. Thereafter, the
Board recommended a reverse takeover of
NewMed Energy (NewMed) which was also
met with vigorous opposition and a public
campaign by a number of shareholders,
including demands for fundamental Board
renewal and the termination of the
NewMed deal. This culminated in the
resignation of all but two members of the
previous Board and overwhelming
shareholder support for the appointment of
six new Board members at an extraordinary
general meeting held on 1 February 2023.
I was elected to the Board and appointed
Chair of Capricorn at that time and am
honoured to serve in this role alongside the
other new members of the Board. We bring
to Capricorn a broad skillset of industry,
shareholder engagement and capital
markets expertise, which is essential for the
Board to deliver against shareholders’ strong
mandate and expectations for change.
The three months since the shareholder
meeting have been a period of extraordinary
energy and renewal and this will continue
as the Board works tirelessly to ensure
Capricorn is managed for all of its diverse
mix of shareholders, with an overriding focus
on shareholder value generation. Since
joining the Board, I have personally met a
wide range of our investors, to ensure the
Board understands shareholders’ concerns
and expectations as we develop our plans for
Capricorn. Almost 75% of Capricorn’s shares
were voted at the February 2023 meeting,
with over 99% of these supporting the
appointment of six new Board members.
Unsurprisingly, the messages from
shareholders have therefore been consistent,
at the heart of which is an expectation for
change and a new approach. This culture
of transparent engagement will continue,
focusing on the acknowledgement of
shareholder concerns and providing clear
explanations for the positions we take.
Immediate priorities
Following the February general meeting,
the Board announced a strategic review
to explore options for Capricorn’s future
direction. Our immediate focus in the
context of this review was to address
the pressing matter of the NewMed
transaction. Having considered the views
of a significant number of shareholders
and their unwillingness to support the
proposed NewMed transaction, as well as
recommendations to vote against the deal
from leading proxy advisory agencies, and
the need for the renewed Board to be able
to consider all available alternative
strategies for Capricorn, the Board advised
shareholders to vote against the NewMed
proposal. At the pending shareholder
meeting, shareholders would have been
asked to consider approving the NewMed
deal, the completion of which remained
subject to a range of conditions from
NewMed, and as such no certainty that
the deal would have been completed on
the then contemplated terms. Shortly
thereafter, the Company and NewMed
mutually agreed on 15 February 2023
the termination with immediate effect
of the business combination agreement,
and therefore the NewMed transaction.
The decision provided the Board with
greater strategic optionality in deciding
Capricorn’s future direction.
We have heard clearly from shareholders
and are pleased to outline five immediate
priorities which have had our focus since
taking office 85 days ago.
1. Return of value
to shareholders
The tax refund in February 2022 from the
Government of India of more than US$1bn
enabled Capricorn to return US$529m of
capital to shareholders in the form of a
tender offer and buyback programme in
2022. As a newly constituted Board, our
first commitment is to outline our plans
to conduct another material distribution
of cash to shareholders within operating
requirements. We have stress tested the
capital requirements of the business,
so we have a clear understanding of how
to manage safely our assets in the current
market environment.
The Board is returning approximately
US$575m via a special dividend of
c.US$450m expected to be paid in May
2023, a further special dividend in Q4
2023 of US$100m dependent upon
certain conditions and a share buyback
of at least US$25m over the next twelve
months. The US$100m special dividend
in Q4 2023 is dependent upon a number
of factors including: addressing our
receivables position in Egypt; the outcome
of conversations with stakeholders in
Egypt around licence extensions and
renegotiation of terms; actual oil and gas
price outcomes for the remainder of 2023;
and the conclusions of our strategic review
as it relates to further cost actions and
future investment in our Egypt business.
The special dividend of approximately
US$$450m, which will be accompanied
by a share consolidation and is subject to
shareholder approval, is expected to be
paid on 23 May as a final cash dividend of
115 pence per share. The consolidation and
special dividend record date is expected to
be 15 May, with dealings in the consolidated
shares (ex-dividend) expected to commence
on 16 May. The Board commits to return to
shareholders all excess cash flow not
required for our go forward core operational
focus both today and on an ongoing basis.
In proposing these returns of value, the
Board has been focused on the need to
ensure Capricorn has sufficient capital and
working capital to operate under a range of
assumptions, in a market which is volatile
and where significant cash receipts are in
some cases beyond our control. Balancing
this is a clear expectation from shareholders
that surplus cash be returned, which is what
we are announcing today.
2. Cost cuts and
cash preservation
On 23 March 2023 we announced a
material cost cutting exercise across
Capricorn. We have commenced an
employee consultation process which
is anticipated to reduce the UK workforce
by ~70% to c.40 people to better reflect the
go forward needs of the business. This will
create a new, leaner organisation to support
the Egypt assets and result in a total global
organisation of c.70 employees. Ongoing
staff costs will be reduced by more than 50%
while still retaining the necessary capability
and headcount to safely and efficiently
achieve our goals. In 2023, there will be
costs associated with this restructuring
which are expected to be offset by in-year
savings, with the full annualised benefit of
the cost reduction to be seen in 2024.
With fewer people, we will require much
less office space and ancillary services.
Capricorn will be moving out of its current
office on Lothian Road, Edinburgh as
planned but will not be moving into the
new offices in Edinburgh which were
outlined in last year’s annual report. The
search for smaller, lower cost alternative
office space in Edinburgh is now underway.
Significantly smaller, low-cost premises will
also be found in London for those limited
activities which need to take place there.
The Board has also reviewed its external
consulting arrangements with a view to
reducing costs and having a fresh start,
ruling a line under the events of the last
12 months and presenting a new face to
the market. We have therefore appointed
Bank of America as corporate broker and
financial adviser to replace four other
banking advisers, and on the
communications side, Camarco.
These cost saving initiatives are expected
to realise identified total gross G&A savings
of at least US$35m, representing a >50%
reduction on 2022 gross G&A. These
savings will be fully realised in 2024.
Opportunities for further savings will
continue to be pursued, with costs to be
aligned to activity on an ongoing basis.
All these initiatives are designed to preserve
cash for the benefit of shareholders, to
meet shareholders’ expectations of
commercial rigour and sound financial